Trademark: 79292215
Word
MODAG
Status Date
Tuesday, July 20, 2021
Registration Number
6422358
Registration Date
Tuesday, July 20, 2021
Filing Date
Friday, January 31, 2020
Published for Opposition
Tuesday, May 4, 2021
5 Pharmaceutical drugs and medicines for the treatment of the nervous system and for the treatment of diseases characterized by pathological protein aggregation; diagnostic preparations for medical purposes
1 Chemical substances, chemical materials, chemical compositions and chemical preparations, all of the foregoing for use in science
44 Medical services in the field of diseases characterized by pathological protein aggregation; Medical diagnosis of nervous system diseases such as neurodegenerative diseases and diseases characterized by pathological protein aggregation; medical services in the field of neurodegenerative diseases; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical analysis for the diagnosis, prognosis and treatment of neurodegenerative diseases and diseases characterized by pathological protein aggregation; providing medical data and information in the field of nervous system diseases such as neurodegenerative diseases and diseases characterized by pathological protein aggregation to healthcare professionals; rental of medical apparatus and equipment, and fittings therefor
10 Medical apparatus and instruments for monitoring molecular biomarkers of neurodegenerative diseases and diseases characterized by pathological protein aggregation such as pathologically modified and/or pathologically aggregated proteins and parts and fittings therefor; Medical diagnostic apparatus for testing molecular biomarkers of neurodegenerative diseases and diseases characterized by pathological protein aggregation such as pathologically modified and/or pathologically aggregated proteins and parts and fittings therefor
42 Scientific and technological services, namely, research and design in the field of neurodegenerative diseases and diseases characterized by pathological protein aggregation; industrial analysis and research services in the field of neurodegenerative diseases and diseases characterized by pathological protein aggregation; biological research; research and development of new products for others; Conducting clinical trials for others in the field of nervous system diseases such as neurodegenerative diseases and diseases characterized by pathological protein aggregation; Scientific laboratory services; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; testing of pharmaceuticals; conducting early evaluations in the field of new pharmaceuticals; drug discovery services; development of pharmaceutical preparations and medicines; research and development of vaccines and medicines; pharmaceutical drug development services
The mark consists of the wording "MODAG" in a stylized font where the letters "M", "D", "A" and "G" are in dark blue, the letter "O" is grey, and the letters "O" and "G" encircle a green dot.
The letters M, D, A and G are dark blue, the letter O is grey and the letters O and G encircle a green dot.
The color(s) dark blue, green and grey is/are claimed as a feature of the mark.
Feb 26, 2024
Teas Change Of Correspondence Received
Feb 26, 2024
Attorney/Dom.Rep.Revoked And/Or Appointed
Feb 26, 2024
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Feb 26, 2024
Applicant/Correspondence Changes (Non-Responsive) Entered
Feb 26, 2024
Teas Change Of Owner Address Received
Dec 19, 2021
Final Decision Transaction Processed By Ib
Dec 1, 2021
Final Disposition Notice Sent To Ib
Dec 1, 2021
Final Disposition Processed
Oct 20, 2021
Final Disposition Notice Created, To Be Sent To Ib
Jul 20, 2021
Registered-Principal Register
May 4, 2021
Official Gazette Publication Confirmation E-Mailed
May 4, 2021
Published For Opposition
May 2, 2021
Notification Processed By Ib
Apr 14, 2021
Notification Of Possible Opposition Sent To Ib
Apr 14, 2021
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Apr 14, 2021
Notification Of Notice Of Publication E-Mailed
Mar 31, 2021
Approved For Pub - Principal Register
Mar 23, 2021
Teas/Email Correspondence Entered
Mar 22, 2021
Correspondence Received In Law Office
Mar 22, 2021
Teas Response To Office Action Received
Oct 19, 2020
Refusal Processed By Ib
Sep 25, 2020
Non-Final Action Mailed - Refusal Sent To Ib
Sep 25, 2020
Refusal Processed By Mpu
Aug 25, 2020
Application Filing Receipt Mailed
Aug 22, 2020
Non-Final Action (Ib Refusal) Prepared For Review
Aug 21, 2020
Non-Final Action Written
Aug 21, 2020
Assigned To Examiner
Aug 21, 2020
New Application Office Supplied Data Entered
Aug 20, 2020
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
